365 related articles for article (PubMed ID: 21784510)
1. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
[TBL] [Abstract][Full Text] [Related]
2. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccine against NgR promotes functional recovery after spinal cord injury in adult rats.
Yu P; Huang L; Zou J; Zhu H; Wang X; Yu Z; Xu XM; Lu PH
Brain Res; 2007 May; 1147():66-76. PubMed ID: 17362886
[TBL] [Abstract][Full Text] [Related]
5. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
6. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
7. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
[TBL] [Abstract][Full Text] [Related]
8. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
[TBL] [Abstract][Full Text] [Related]
9. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
Yang G; Tang WY
Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
[TBL] [Abstract][Full Text] [Related]
10. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
11. Combined NgR vaccination and neural stem cell transplantation promote functional recovery after spinal cord injury in adult rats.
Xu CJ; Xu L; Huang LD; Li Y; Yu PP; Hang Q; Xu XM; Lu PH
Neuropathol Appl Neurobiol; 2011 Feb; 37(2):135-55. PubMed ID: 20819171
[TBL] [Abstract][Full Text] [Related]
12. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
[TBL] [Abstract][Full Text] [Related]
13. Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats.
Lu XM; Mao M; Xiao L; Yu Y; He M; Zhao GY; Tang JJ; Feng S; Li S; He CM; Wang YT
Neurotherapeutics; 2019 Apr; 16(2):381-393. PubMed ID: 30843154
[TBL] [Abstract][Full Text] [Related]
14. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
15. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
Hunt D; Coffin RS; Anderson PN
J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the behavioral and anatomical outcomes in sub-acute and chronic spinal cord injury models following treatment with human mesenchymal precursor cell transplantation and recombinant decorin.
Hodgetts SI; Simmons PJ; Plant GW
Exp Neurol; 2013 Oct; 248():343-59. PubMed ID: 23867131
[TBL] [Abstract][Full Text] [Related]
17. Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth: a potential strategy for axonal regeneration.
Xu G; Nie DY; Chen JT; Wang CY; Yu FG; Sun L; Luo XG; Ahmed S; David S; Xiao ZC
J Neurochem; 2004 Nov; 91(4):1018-23. PubMed ID: 15525355
[TBL] [Abstract][Full Text] [Related]
18. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
Nyatia E; Lang DM
Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
[TBL] [Abstract][Full Text] [Related]
19. Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion.
Wang X; Yigitkanli K; Kim CY; Sekine-Komo T; Wirak D; Frieden E; Bhargava A; Maynard G; Cafferty WB; Strittmatter SM
J Neurotrauma; 2014 Dec; 31(24):1955-66. PubMed ID: 24964223
[TBL] [Abstract][Full Text] [Related]
20. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.
Peterson SL; Nguyen HX; Mendez OA; Anderson AJ
J Neurosci; 2015 Mar; 35(10):4332-49. PubMed ID: 25762679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
